{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T02:09:02Z","timestamp":1768097342912,"version":"3.49.0"},"reference-count":65,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.1248\/bpb.b22-00185","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T22:10:34Z","timestamp":1661983834000},"page":"1259-1268","source":"Crossref","is-referenced-by-count":6,"title":["Development of a Highly Sensitive and Rapid Liquid Chromatography\u2013Tandem Mass Spectrometric Method Using a Basic Mobile Phase Additive to Determine the Characteristics of the Urinary Metabolites for Niemann\u2013Pick Disease Type C"],"prefix":"10.1248","volume":"45","author":[{"given":"Masamitsu","family":"Maekawa","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"},{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Tottori University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kumondai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"},{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[{"name":"Division of Functional Genomics, Research Centre for Bioscience and Technology, Faculty of Medicine, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torayuki","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, National Center for Child Health and Development"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikatsu","family":"Eto","sequence":"additional","affiliation":[{"name":"Advanced Clinical Research Center, Institute for Neurological Disorders"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Chemicals Evaluation and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariyasu","family":"Mano","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"},{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Vanier MT. Niemann\u2013Pick disease type C. Orphanet J. Rare Dis.<\/i>, 5<\/b>, 16 (2010).","DOI":"10.1186\/1750-1172-5-16"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. Recommendations for the diagnosis and management of Niemann\u2013Pick disease type C: an update. Mol. Genet. Metab.<\/i>, 106<\/b>, 330\u2013344 (2012).","DOI":"10.1016\/j.ymgme.2012.03.012"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Geberhiwot T, Moro A, Dardis A, et al.<\/i> Consensus clinical management guidelines for Niemann\u2013Pick disease type C. Orphanet J. Rare Dis.<\/i>, 13<\/b>, 50 (2018).","DOI":"10.1186\/s13023-018-0785-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell<\/i>, 137<\/b>, 1213\u20131224 (2009).","DOI":"10.1016\/j.cell.2009.03.049"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, Brady RO. A defect in cholesterol esterification in Niemann\u2013Pick disease (type C) patients. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 82<\/b>, 8247\u20138251 (1985).","DOI":"10.1073\/pnas.82.23.8247"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Pentchev PG, Boothe AD, Kruth HS, Weintroub H, Stivers J, Brady RO. A genetic storage disorder in BALB\/C mice with a metabolic block in esterification of exogenous cholesterol. J. Biol. Chem.<\/i>, 259<\/b>, 5784\u20135791 (1984).","DOI":"10.1016\/S0021-9258(18)91082-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, Brady RO. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 82<\/b>, 8247\u20138251 (1985).","DOI":"10.1073\/pnas.82.23.8247"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Vanier MT. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim. Biophys. Acta BBALipids Lipid Metab.<\/i>, 750<\/b>, 178\u2013184 (1983).","DOI":"10.1016\/0005-2760(83)90218-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Svennerholm L, Vanier MT. The distribution of lipids in the human nervous system. IV. Fatty acid composition of major sphingolipids of human infant brain. Brain Res.<\/i>, 55<\/b>, 413\u2013423 (1973).","DOI":"10.1016\/0006-8993(73)90306-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study. Lancet Neurol.<\/i>, 6<\/b>, 765\u2013772 (2007).","DOI":"10.1016\/S1474-4422(07)70194-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Maekawa M, Mano N. Identification and evaluation of biomarkers for Niemann\u2013Pick disease type C based on chemical analysis techniques. Chromatography<\/i>, 41<\/b>, 19\u201329 (2020).","DOI":"10.15583\/jpchrom.2020.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Maekawa M, Iwahori A, Mano N. Biomarker analysis of Niemann\u2013Pick disease type C using chromatography and mass spectrometry. J. Pharm. Biomed. Anal.<\/i>, 191<\/b>, 113622 (2020).","DOI":"10.1016\/j.jpba.2020.113622"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Maekawa M, Mano N. Cutting-edge LC\u2013MS\/MS applications in clinical mass spectrometry: focusing on analysis of drugs and metabolites. Biomed. Chromatogr.<\/i>, 36<\/b>, e5347 (2022).","DOI":"10.1002\/bmc.5347"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Jiang X, Sidhu R, Porter FD, Yanjanin NM, Speak AO, te Vruchte DT, Platt FM, Fujiwara H, Scherrer DE, Zhang J, Dietzen DJ, Schaffer JE, Ory DS. A sensitive and specific LC-MS\/MS method for rapid diagnosis of Niemann\u2013Pick C1 disease from human plasma. J. Lipid Res.<\/i>, 52<\/b>, 1435\u20131445 (2011).","DOI":"10.1194\/jlr.D015735"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, Olzeski D, Sidhu R, Dietzen DJ, Fu R, Wassif CA, Yanjanin NM, Marso SP, House J, Vite C, Schaffer JE, Ory DS. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann\u2013Pick C1 disease. Sci. Transl. Med.<\/i>, 2<\/b>, 56ra81 (2010).","DOI":"10.1126\/scitranslmed.3001417"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Welford RWD, Garzotti M, Marques Louren\u00e7o C, Mengel E, Marquardt T, Reunert J, Amraoui Y, Kolb SA, Morand O, Groenen P. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann\u2013Pick disease type C in a retrospective study. PLOS ONE<\/i>, 9<\/b>, e114669 (2014).","DOI":"10.1371\/journal.pone.0114669"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sidhu R, Mondjinou Y, Qian M, Song H, Kumar AB, Hong X, Hsu F-F, Dietzen DJ, Yanjanin NM, Porter FD, Berry-Kravis E, Vite CH, Gelb MH, Schaffer JE, Ory DS, Jiang X. N<\/i>-acyl-O<\/i>-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann\u2013Pick C1 disease. J. Lipid Res.<\/i>, 60<\/b>, 1410\u20131424 (2019).","DOI":"10.1194\/jlr.RA119000157"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Maekawa M, Jinnoh I, Matsumoto Y, et al.<\/i> Structural determination of lysosphingomyelin-509 and discovery of novel class lipids from patients with Niemann\u2013Pick disease type C. Int. J. Mol. Sci.<\/i>, 20<\/b>, 5018 (2019).","DOI":"10.3390\/ijms20205018"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sidhu R, Kell P, Dietzen DJ, Farhat NY, Do AND, Porter FD, Berry-Kravis E, Vite CH, Reunert J, Marquardt T, Giugliani R, Louren\u00e7o CM, Bodamer O, Wang RY, Plummer E, Schaffer JE, Ory DS, Jiang X. Application of N<\/i>-palmitoyl-O<\/i>-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann\u2013Pick type C disease. Mol. Genet. Metab.<\/i>, 129<\/b>, 292\u2013302 (2020).","DOI":"10.1016\/j.ymgme.2020.01.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Iwahori A, Maekawa M, Narita A, Kato A, Sato T, Ogura J, Sato Y, Kikuchi M, Noguchi A, Higaki K, Okuyama T, Takahashi T, Eto Y, Mano N. Development of a diagnostic screening strategy for Niemann\u2013Pick diseases based on simultaneous liquid chromatography-tandem mass spectrometry analyses of N<\/i>-palmitoyl-O<\/i>-phosphocholine-serine and sphingosylphosphorylcholine. Biol. Pharm. Bull.<\/i>, 43<\/b>, 1398\u20131406 (2020).","DOI":"10.1248\/bpb.b20-00400"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Jiang X, Sidhu R, Orsini JJ, Farhat NY, Porter FD, Berry-Kravis E, Schaffer JE, Ory DS. Diagnosis of Niemann\u2013Pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots. Mol. Genet. Metab.<\/i>, 126<\/b>, 183\u2013187 (2019).","DOI":"10.1016\/j.ymgme.2018.08.007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sidhu R, Kell P, Dietzen DJ, Farhat NY, Do AND, Porter FD, Berry-Kravis E, Reunert J, Marquardt T, Giugliani R, Louren\u00e7o CM, Wang RY, Movsesyan N, Plummer E, Schaffer JE, Ory DS, Jiang X. Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann\u2013Pick disease type C1. Mol. Genet. Metab.<\/i>, 131<\/b>, 405\u2013417 (2020).","DOI":"10.1016\/j.ymgme.2020.11.005"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Jiang X, Sidhu R, Mydock-McGrane L, Hsu F-F, Covey DF, Scherrer DE, Earley B, Gale SE, Farhat NY, Porter FD, Dietzen DJ, Orsini JJ, Berry-Kravis E, Zhang X, Reunert J, Marquardt T, Runz H, Giugliani R, Schaffer JE, Ory DS. Development of a bile acid-based newborn screen for Niemann\u2013Pick disease type C. Sci. Transl. Med.<\/i>, 8<\/b>, 337ra63 (2016).","DOI":"10.1126\/scitranslmed.aaf2326"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mazzacuva F, Mills P, Mills K, Camuzeaux S, Gissen P, Nicoli E-R, Wassif C, te Vruchte D, Porter FD, Maekawa M, Mano N, Iida T, Platt F, Clayton PT. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann\u2013Pick C disease. FEBS Lett.<\/i>, 590<\/b>, 1651\u20131662 (2016).","DOI":"10.1002\/1873-3468.12196"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Alvelius G, Hjalmarson O, Griffiths WJ, Bj\u00f6rkhem I, Sj\u00f6vall J. Identification of unusual 7-oxygenated bile acid sulfates in a patient with Niemann\u2013Pick disease, type C. J. Lipid Res.<\/i>, 42<\/b>, 1571\u20131577 (2001).","DOI":"10.1016\/S0022-2275(20)32210-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Maekawa M, Misawa Y, Sotoura A, Yamaguchi H, Togawa M, Ohno K, Nittono H, Kakiyama G, Iida T, Hofmann AF, Goto J, Shimada M, Mano N. LC\/ESI-MS\/MS analysis of urinary 3\u03b2-sulfooxy-7\u03b2-N<\/i>-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann\u2013Pick type C disease. Steroids<\/i>, 78<\/b>, 967\u2013972 (2013).","DOI":"10.1016\/j.steroids.2013.05.017"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Maekawa M, Shimada M, Ohno K, Togawa M, Nittono H, Iida T, Hofmann AF, Goto J, Yamaguchi H, Mano N. Focused metabolomics using liquid chromatography\/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann\u2013Pick disease type C and 3\u03b2-hydroxysteroid dehydrogenase deficiency. Ann. Clin. Biochem.<\/i>, 52<\/b>, 576\u2013587 (2015).","DOI":"10.1177\/0004563214568871"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Maekawa M, Omura K, Sekiguchi S, Iida T, Saigusa D, Yamaguchi H, Mano N. Identification of two sulfated cholesterol metabolites found in the urine of a patient with Niemann\u2013Pick disease type C as novel candidate diagnostic markers. Mass Spectrom.<\/i> (Tokyo), 5<\/b>, S0053 (2016).","DOI":"10.5702\/massspectrometry.S0053"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Maekawa M, Jinnoh I, Narita A, Iida T, Saigusa D, Iwahori A, Nittono H, Okuyama T, Eto Y, Ohno K, Clayton PT, Yamaguchi H, Mano N. Investigation of diagnostic performance of five urinary cholesterol metabolites for Niemann\u2013Pick disease type C. J. Lipid Res.<\/i>, 60<\/b>, 2074\u20132081 (2019).","DOI":"10.1194\/jlr.M093971"},{"key":"30","unstructured":"30) Masamitsu M, Anna I, Nariyasu M. Identification and diagnostic performance evaluation of biomarkers for Niemann\u2013Pick disease type C using mass spectrometry. Japanese Journal of Clinical Chemistry<\/i>, 50<\/b>, 20\u201326 (2021)."},{"key":"31","unstructured":"31) Maekawa M, Yamaguchi H, Nariyasu M. Conjugated cholesterol metabolites as urinary diagnostic biomarkers of Niemann\u2013Pick disease type C. JSBMS Lett.<\/i>, 43<\/b>, 45\u201350 (2018)."},{"key":"32","unstructured":"32) Maekawa M, Yamaguchi H, Mano N. Discovery of diagnostic markers for Niemann\u2013Pick disease type C by focused metabolomics. Japanese Journal of Clinical Chemistry<\/i>, 47<\/b>, 161\u2013168 (2018)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Mano N, Maekawa M, Yamaguchi H. Clinical chemistry based on highly accurate separation analysis technology. Chromatography<\/i>, 39<\/b>, 49\u201357 (2018).","DOI":"10.15583\/jpchrom.2018.003"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Maekawa M, Yamaguchi H, Mano N. Analytical Technologies Used in the Medical Front. Bunseki Kagaku<\/i>, 66<\/b>, 413\u2013419 (2017).","DOI":"10.2116\/bunsekikagaku.66.413"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Clayton PT. Disorders of bile acid synthesis. J. Inherit. Metab. Dis.<\/i>, 34<\/b>, 593\u2013604 (2011).","DOI":"10.1007\/s10545-010-9259-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Clayton PT. Applications of mass spectrometry in the study of inborn errors of metabolism. J. Inherit. Metab. Dis.<\/i>, 24<\/b>, 139\u2013150 (2001).","DOI":"10.1023\/A:1010358715835"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Clayton PT. Inborn errors of bile acid metabolism. J. Inherit. Metab. Dis.<\/i>, 14<\/b>, 478\u2013496 (1991).","DOI":"10.1007\/BF01797919"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Tan A, Fanaras JC. Use of high-pH (basic\/alkaline) mobile phases for LC\u2013MS or LC\u2013MS\/MS bioanalysis. Biomed. Chromatogr.<\/i>, 33<\/b>, e4409 (2019).","DOI":"10.1002\/bmc.4409"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Tan A, Gu G, Gui X, Wu Y, Bolger G, Licollari A, Fanaras JC. Improving the selectivity and sensitivity for quantifying 8-\u03b1-hydroxy-mutilin in rabbit tissues by using basic mobile phases and negative ionization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, 1072<\/b>, 142\u2013148 (2018).","DOI":"10.1016\/j.jchromb.2017.11.008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Tan A, Wu Y, Wong M, Licollari A, Bolger G, Fanaras JC, Shopp G, Helson L. Use of basic mobile phase to improve chromatography and boost sensitivity for quantifying tetrahydrocurcumin in human plasma by LC-MS\/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, 1028<\/b>, 86\u201393 (2016).","DOI":"10.1016\/j.jchromb.2016.06.010"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Zhang D, Fu Y, Gale JP, Aubry AF, Arnold ME. A sensitive method for the determination of entecavir at picogram per milliliter level in human plasma by solid phase extraction and high-pH LC-MS\/MS. J. Pharm. Biomed. Anal.<\/i>, 49<\/b>, 1027\u20131033 (2009).","DOI":"10.1016\/j.jpba.2009.02.003"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Peng L, Farkas T. Analysis of basic compounds by reversed-phase liquid chromatography-electrospray mass spectrometry in high-pH mobile phases. J. Chromatogr. A<\/i>, 1179<\/b>, 131\u2013144 (2008).","DOI":"10.1016\/j.chroma.2007.11.048"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Ozaki H, Nakano Y, Sakamaki H, Yamanaka H, Nakai M. Basic eluent for rapid and comprehensive analysis of fatty acid isomers using reversed-phase high performance liquid chromatography\/Fourier transform mass spectrometry. J. Chromatogr. A<\/i>, 1585<\/b>, 113\u2013120 (2019).","DOI":"10.1016\/j.chroma.2018.11.057"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Nakano Y, Nagasawa E, Uchida T, Sakamaki H. Highly sensitive detection of pesticide residues by LC-MS\/MS using ammonia solution as an eluent. Bunseki Kagaku<\/i>, 69<\/b>, 141\u2013150 (2020).","DOI":"10.2116\/bunsekikagaku.69.141"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Takkis K, Aro R, K\u00f5rgvee LT, Varendi H, Lass J, Herodes K, Kipper K. Signal enhancement in the HPLC-ESI-MS\/MS analysis of spironolactone and its metabolites using HFIP and NH4F as eluent additives. Anal. Bioanal. Chem.<\/i>, 409<\/b>, 3145\u20133151 (2017).","DOI":"10.1007\/s00216-017-0255-4"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Li XS, Li S, Kellermann G. Simultaneous determination of three estrogens in human saliva without derivatization or liquid-liquid extraction for routine testing via<\/i> miniaturized solid phase extraction with LC-MS\/MS detection. Talanta<\/i>, 178<\/b>, 464\u2013472 (2018).","DOI":"10.1016\/j.talanta.2017.09.062"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Gaudl A, Kratzsch J, Bae YJ, Kiess W, Thiery J, Ceglarek U. Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair. J. Chromatogr. A<\/i>, 1464<\/b>, 64\u201371 (2016).","DOI":"10.1016\/j.chroma.2016.07.087"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) H\u00e4kkinen MR, Heinosalo T, Saarinen N, Linnanen T, Voutilainen R, Lakka T, J\u00e4\u00e4skel\u00e4inen J, Poutanen M, Auriola S. Analysis by LC\u2013MS\/MS of endogenous steroids from human serum, plasma, endometrium and endometriotic tissue. J. Pharm. Biomed. Anal.<\/i>, 152<\/b>, 165\u2013172 (2018).","DOI":"10.1016\/j.jpba.2018.01.034"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Boegh Andersen I, Lohman Brasen C, Skov Madsen J, Schmedes A. Quantitation of vitamin K1 in serum using online SPE-LC-MS\/MS and the challenges of working with vitamin K. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, 1117<\/b>, 41\u201348 (2019).","DOI":"10.1016\/j.jchromb.2019.04.010"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Abe A, Maekawa M, Sato T, Sato Y, Kumondai M, Takahashi H, Kikuchi M, Higaki K, Ogura J, Mano N. Metabolic alteration analysis of steroid hormones in Niemann\u2013Pick disease type C model cell using liquid chromatography\/tandem mass spectrometry. Int. J. Mol. Sci.<\/i>, 23<\/b>, 4459 (2022).","DOI":"10.3390\/ijms23084459"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Ohnishi T, Balan S, Toyoshima M, et al.<\/i> Investigation of betaine as a novel psychotherapeutic for schizophrenia. EBioMedicine<\/i>, 45<\/b>, 432\u2013446 (2019).","DOI":"10.1016\/j.ebiom.2019.05.062"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Iida T, Kakiyama G, Hibiya Y, Miyata S, Inoue T, Ohno K, Goto T, Mano N, Goto J, Nambara T, Hofmann AF. Chemical synthesis of the 3-sulfooxy-7-N-acetylglucosaminyl-24-amidated conjugates of 3\u03b2,7\u03b2-dihydroxy-5-cholen-24-oic acid, and related compounds: Unusual, major metabolites of bile acid in a patient with Niemann\u2013Pick disease type C1. Steroids<\/i>, 71<\/b>, 18\u201329 (2006).","DOI":"10.1016\/j.steroids.2005.07.008"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Kakiyama G, Muto A, Shimada M, Mano N, Goto J, Hofmann AF, Iida T. Chemical synthesis of 3beta-sulfooxy-7beta-hydroxy-24-nor-5-cholenoic acid: an internal standard for mass spectrometric analysis of the abnormal delta5-bile acids occurring in Niemann\u2013Pick disease. Steroids<\/i>, 74<\/b>, 766\u2013772 (2009).","DOI":"10.1016\/j.steroids.2009.04.007"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Maekawa M, Mori M, Fujiyoshi M, Suzuki H, Yanai K, Noda A, Tanaka M, Takasaki S, Kikuchi M, Akasaka K, Kisara S, Matsuura M, Hisamichi K, Sato M, Goto J, Shimada M, Yamaguchi H, Mano N. A direct injection LC\/ESI-MS\/MS analysis of urinary cyclophosphamide as an anticancer drug for monitoring occupational exposure. Chromatography<\/i>, 39<\/b>, 41\u201347 (2018).","DOI":"10.15583\/jpchrom.2017.023"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Maekawa M, Narita A, Jinnoh I, Iida T, Marquardt T, Mengel E, Eto Y, Clayton PT, Yamaguchi H, Mano N. Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann\u2013Pick disease type C. Clin. Chim. Acta<\/i>, 494<\/b>, 58\u201363 (2019).","DOI":"10.1016\/j.cca.2019.03.1610"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Shoji S, Maekawa M, Ogura J, Sato T, Mano N. Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics. Biochim. Biophys. Acta Mol. Cell Biol. Lipids<\/i>, 1867<\/b>, 159135 (2022).","DOI":"10.1016\/j.bbalip.2022.159135"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Goto J, Kato H, Nambara T. Separation of monosulfated bile acids by high-performance liquid chromatography. J. Liq. Chromatogr.<\/i>, 3<\/b>, 645\u2013655 (1980).","DOI":"10.1080\/01483918008060180"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Goto J, Chikai T, Nambara T. Separation of bile acid 7- and 12-sulfates by high performance liquid chromatography with pre-column fluorescence labeling. Anal. Sci.<\/i>, 2<\/b>, 175\u2013178 (1986).","DOI":"10.2116\/analsci.2.175"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Maekawa M, Mano N. Cutting-edge LC\u2013MS\/MS applications in clinical mass spectrometry: focusing on analysis of drugs and metabolites. Biomed. Chromatogr.<\/i>, 36<\/b>, e5347 (2022).","DOI":"10.1002\/bmc.5347"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Hirasawa T, Kikuchi M, Shigeta K, Takasaki S, Sato Y, Sato T, Ogura J, Onodera K, Fukuhara N, Onishi Y, Maekawa M, Mano N. High-throughput liquid chromatography\/electrospray ionization\u2013tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma. Biomed. Chromatogr.<\/i>, 35<\/b>, e5124 (2021).","DOI":"10.1002\/bmc.5124"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Sato Y, Shigeta K, Hirasawa T, Sato T, Ogura J, Maekawa M, Ebata A, Hamanaka Y, Tada H, Ishida T, Kikuchi M, Mano N. Establishment of an analytical method for simultaneous quantitation of CDK4\/6 inhibitors, aromatase inhibitors, and an estrogen receptor antagonist in human plasma using LC-ESI-MS\/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, 1173<\/b>, 122655 (2021).","DOI":"10.1016\/j.jchromb.2021.122655"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Sato T, Suzuka M, Sato Y, Iwabuchi R, Kobayashi D, Ogura J, Takasaki S, Yokota M, Tsukamoto T, Hayakawa Y, Kikuchi M, Maekawa M, Mano N. Development of a simultaneous analytical method for clozapine and its metabolites in human plasma using liquid chromatography\/electrospray ionization tandem mass spectrometry with linear range adjusted by in-source collision-induced dissociation. Biomed. Chromatogr.<\/i>, 35<\/b>, e5094 (2021).","DOI":"10.1002\/bmc.5094"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Takasaki S, Hirasawa T, Sato Y, Maekawa M, Tsukamoto T, Kikuchi M, Ogura J, Hayakawa Y, Matsuda Y, Oishi H, Sado T, Noda M, Okada Y, Yamaguchi H, Mano N. Simultaneous analysis of drugs administered to lung-transplanted patients using liquid chromatography\u2013tandem mass spectrometry for therapeutic drug monitoring. Biomed. Chromatogr.<\/i>, 35<\/b>, e5067 (2021).","DOI":"10.1002\/bmc.5067"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Thakare R, Chhonker YS, Gautam N, Alamoudi JA, Alnouti Y. Quantitative analysis of endogenous compounds. J. Pharm. Biomed. Anal.<\/i>, 128<\/b>, 426\u2013437 (2016).","DOI":"10.1016\/j.jpba.2016.06.017"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Bader M. A systematic approach to standard addition methods in instrumental analysis. J. Chem. Educ.<\/i>, 57<\/b>, 703\u2013706 (1980).","DOI":"10.1021\/ed057p703"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/9\/45_b22-00185\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:30:43Z","timestamp":1715232643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/9\/45_b22-00185\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b22-00185","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"b22-00185"}}